← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

Name Funds
holding
Growth Growth % Fund
value
TCRR
51
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
62 -19 -23% $21M
CABA icon
52
Cabaletta Bio
CABA
$263M
60 +6 +11% $183M
MBIO icon
53
Mustang Bio
MBIO
$2.93M
60 -7 -10% $4.72M
NKGN icon
54
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
60 +7 +13% $159M
ADVM icon
55
DELISTED
Adverum Biotechnologies
ADVM
58 -20 -26% $33.1M
GMDA
56
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
55 -7 -11% $29.1M
ATNX
57
DELISTED
Athenex, Inc. Common Stock
ATNX
53 -19 -26% $6.01M
TSHA icon
58
Taysha Gene Therapies
TSHA
$1.22B
52 -2 -4% $43.8M
ATHX
59
DELISTED
Athersys, Inc. Common Stock
ATHX
49 +5 +11% $2.76M
FBIO icon
60
Fortress Biotech
FBIO
$63.7M
49 -15 -23% $18M
ORTX
61
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
48 +1 +2% $16.5M
MRKR icon
62
Marker Therapeutics
MRKR
$15.3M
47 +2 +4% $5.24M
CERO icon
63
DELISTED
CERo Therapeutics
CERO
45 -20 -31% $101M
NGNE icon
64
Neurogene
NGNE
$479M
44 -8 -15% $8.66M
BCLI icon
65
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
43 +1 +2% $6.16M
MESO icon
66
Mesoblast
MESO
$1.81B
42 +5 +14% $7.89M
RUBY
67
DELISTED
Rubius Therapeutics, Inc
RUBY
42 -20 -32% $11.2M
ABEO icon
68
Abeona Therapeutics
ABEO
$266M
40 +16 +67% $28.5M
CLLS icon
69
Cellectis
CLLS
$111M
39 -10 -20% $18.3M
DBTX
70
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
39 -1 -3% $36.2M
SIOX
71
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
37 -3 -8% $8.96M
LNAI icon
72
Lunai Bioworks
LNAI
$3.74M
36 -6 -14% $3.73M
GRML
73
Greenland Mines Ltd
GRML
$92.9M
35 +1 +3% $104M
SQZ
74
DELISTED
SQZ Biotechnologies Company
SQZ
35 -13 -27% $9.35M
INMB icon
75
INmune Bio
INMB
$45.8M
34 +1 +3% $10.3M